The rationality of combining second-generation antiandrogens with 177Lu-PSMA or its alpha-emitting congeners for better and durable results: will this dominate the therapeutic landscape and be an upfront consideration in metastatic castration-resistant prostate cancer in the coming years?
作者信息
Basu Sandip, Parghane Rahul V, Joshi Amit, Prabhash Kumar, Banerjee Sharmila
机构信息
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe.
Homi Bhabha National Institute, Mumbai, India.
出版信息
Nucl Med Commun. 2018 Dec;39(12):1061-1063. doi: 10.1097/MNM.0000000000000932.
PMID:30339554
Abstract
摘要
Zotero 插件